What the Walgreens-Duane Reade Deal Signals for M&A

In late February, Walgreens (WAG), the country's largest drug-store chain, announced its $1.1 billion plan to acquire Duane Reade, the New York metro area's largest and most iconic drug chain. The news had New Yorkers wondering about the fate of the familiar brand and sparked debate on Wall Street about the current deal market.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.